Home/Filings/4/0001104659-20-078202
4//SEC Filing

Chen Jing 4

Accession 0001104659-20-078202

CIK 0001563665other

Filed

Jun 28, 8:00 PM ET

Accepted

Jun 29, 7:51 PM ET

Size

8.1 KB

Accession

0001104659-20-078202

Insider Transaction Report

Form 4
Period: 2020-06-25
Chen Jing
Director
Transactions
  • Award

    Stock Option (right to buy)

    2020-06-25+9,57921,517 total
    Exercise: $2.52Exp: 2030-06-25Common Stock, par value $0.01 per share (9,579 underlying)
  • Award

    Stock Option (right to buy)

    2020-06-25+11,93811,938 total
    Exercise: $2.52Exp: 2030-06-25Common Stock, par value $0.01 per share (11,938 underlying)
Footnotes (2)
  • [F1]This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 25, 2020, December 25, 2020, March 25, 2021, and June 25, 2021.
  • [F2]This Stock Option was granted in lieu of 2020 cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2020, September 30, 2020 and December 31, 2020.

Issuer

Biostage, Inc.

CIK 0001563665

Entity typeother

Related Parties

1
  • filerCIK 0001727177

Filing Metadata

Form type
4
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 7:51 PM ET
Size
8.1 KB